Categories
Projects
May 20, 2026
Presented by Bryter
Bryter partnered with a life sciences creative agency to support the development of a patient facing campaign for a treatment targeting relapsed/refractory multiple myeloma (RRMM).
The campaign needed to resonate with a highly specific and experienced patient group, individuals who had progressed beyond first-line therapy as well as their caregivers. The client required:
Given the complexity of the disease and treatment journey, it was critical to ensure communications were both clinically credible and emotionally meaningful.
Bryter designed and delivered a sequential, mixed method concept and message testing programme, combining qualitative depth with quantitative validation.
1. Heatmapping and highlighting pre-task
2. Qualitative Concept Exploration
3. Message Evaluation and Optimisation
This structured approach ensured the client could move from exploratory insight to clear, evidence-based decisions
The study delivered a clear roadmap for campaign development, including:
Bryter combines deep healthcare expertise with advanced creative and message testing methodologies to ensure communications work in the real world. By grounding campaigns in patient and caregiver insight, we help healthcare brands deliver messaging that is not only compliant and accurate but truly impactful.
Market research specialties
Presented by:
Featured Expert
Sign Up for
Updates
Get content that matters, written by top insights industry experts, delivered right to your inbox.